Renalytix AI

Renalytix AI is a company that specializes in the utilization of artificial intelligence (AI) to develop diagnostic tools for kidney disease. Their key product, KidneyIntelX, is designed to predict and slow down kidney disease progression in patients with Type 2 diabetes and those of African ancestry. By analyzing a combination of predictive blood-based biomarkers and electronic health record information, the tool helps clinicians identify patients who might be at high risk of kidney disease, giving them the opportunity to implement treatment strategies that may delay or prevent the onset of end-stage kidney disease and costly interventions.

Based in New York, the company's mission is to improve clinical management of patients with kidney disease, reduce patient risk and healthcare costs. Renalytix AI aims to make a significant contribution to global health by offering practical solutions to a major public health issue. The company's efforts align with the global push for preventive healthcare, emphasizing the need to diagnose conditions early for better patient outcomes.